About Oncology Institute Inc
Ticker
info
TOI
Trading on
info
NASDAQ
ISIN
info
US68236X1000
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
Dr. Daniel Virnich FACHE, M.B.A., M.D.
Headquarters
info
18000 Studebaker Road, Cerritos, CA, United States, 90703
Employees
info
825
Website
info
https://theoncologyinstitute.com
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Metrics
BasicAdvanced
Market cap
info
$288M
P/E ratio
info
-
EPS
info
-$0.67
Dividend Yield
info
0.00%
Beta
info
0.16
Forward P/E ratio
info
0
EBIDTA
info
$-40M
Ex dividend date
info
-
Price & volume
Market cap
info
$288M
Average daily volume
info
3.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0.66
Price to book
info
0.76
Earnings
EPS
info
-$0.67
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-40M
Revenues (TTM)
info
$424M
Revenues per share (TTM)
info
$5.28
Technicals
Beta
info
0.16
52-week High
info
$4.88
52-week Low
info
$0.17
50-day moving average
info
$3.75
200-day moving average
info
$2.69
Short ratio
info
2.4
Short %
info
6.25%
Management effectiveness
ROE (TTM)
info
-651.69%
ROA (TTM)
info
-17.28%
Profit margin
info
-15.53%
Gross profit margin
info
$63.8M
Operating margin
info
-9.36%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
21.50%
Share stats
Outstanding Shares
info
93.5M
Float
info
77.6M
Insiders %
info
8.88%
Institutions %
info
43.33%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$7.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.18
-$0.06
-191.83%
Q3 • 24Missed
-$0.14
-$0.08
-78.75%
Q4 • 24Missed
-$0.21
-
-
Q1 • 25Beat
-$0.15
-$0.12
-25.00%
Q2 • 25Missed
-$0.14
-$0.11
-27.27%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$120M
$-17M
-14.20%
Q2 • 25
$137M
$-16.5M
-12.09%
Q3 • 25
13.99%
-2.97%
-14.88%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$160M
$169M
105.62%
Q2 • 25
$164M
$176M
107.50%
Q3 • 25
2.39%
4.21%
1.78%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-10.2M
$-1.2M
$2M
$-11.4M
Q2 • 25
$-12.6M
$-0.6M
$10.6M
$-13.2M
Q3 • 25
23.80%
-50.00%
439.99%
15.99%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Oncology Institute Inc share?
Collapse

Oncology Institute Inc shares are currently traded for undefined per share.

How many shares does Oncology Institute Inc have?
Collapse

Oncology Institute Inc currently has 93.5M shares.

Does Oncology Institute Inc pay dividends?
Collapse

No, Oncology Institute Inc doesn't pay dividends.

What is Oncology Institute Inc 52 week high?
Collapse

Oncology Institute Inc 52 week high is $4.88.

What is Oncology Institute Inc 52 week low?
Collapse

Oncology Institute Inc 52 week low is $0.17.

What is the 200-day moving average of Oncology Institute Inc?
Collapse

Oncology Institute Inc 200-day moving average is $2.69.

Who is Oncology Institute Inc CEO?
Collapse

The CEO of Oncology Institute Inc is Dr. Daniel Virnich FACHE, M.B.A., M.D..

How many employees Oncology Institute Inc has?
Collapse

Oncology Institute Inc has 825 employees.

What is the market cap of Oncology Institute Inc?
Collapse

The market cap of Oncology Institute Inc is $288M.

What is the P/E of Oncology Institute Inc?
Collapse

The current P/E of Oncology Institute Inc is null.

What is the EPS of Oncology Institute Inc?
Collapse

The EPS of Oncology Institute Inc is -$0.67.

What is the PEG Ratio of Oncology Institute Inc?
Collapse

The PEG Ratio of Oncology Institute Inc is null.

What do analysts say about Oncology Institute Inc?
Collapse

According to the analysts Oncology Institute Inc is considered a buy.